Injectable Drug Delivery Market is expected to grow at a CAGR of 11.3% during the forecast period. Global Injectable Drug Delivery Market value USD 772.9 Bn. in 2023 and it is expected to reach USD 1631.3 Bn. by 2030.Injectable Drug delivery Market Overview
The increase in the prevalence of cancer and diabetes in recent years were the injectable drugs are used in the treatment and the current trend in developing the safety syringes, prefilled syringes, and auto-injectors are amplifying the market. Major factors obstructing the global injectable drug delivery market are the presence of alternatives to drug delivery procedures and safety concerns due to the increase in needle sticks during treatment. However, the increasing demand for generic injectable and bio similar is expected to generate new growth opportunities in the future for the injectable drug delivery marketTo know about the Research Methodology:-Request Free Sample Report The report study has analyzed revenue impact of covid-19 pandemic on the sales revenue of market leaders, market followers and disrupters in the report and same is reflected in our analysis. According to the World Health Organization (WHO), in 2014, the prevalence of diabetes over the age of 18 years has increased to xx%. According to the National Cancer Institute, cancer is considered as one of the prominent causes of death globally. Around xx Mn cancer-related deaths were reported in 2022 around the globe. In terms of application, hormone disorders held the largest portion of the global market in 2022, owing to the growing frequency of hormonal disorders, such as diabetes. Based on the end-user, the home care segment held the largest portion of the market, because of the high use of self-injectable pens and other devices at home majorly by diabetic patients.
Injectable Drug Delivery Market Dynamics
Rising Demand Due to the Growing Burden of Chronic Diseases Treatment of many infectious diseases, such as bacterial, viral, fungal, and parasitic infections, depends on injectable medication administration. To quickly and effectively establish drug concentrations in the bloodstream and target tissues, a variety of intravenous antibiotics, antiviral medications, antifungal agents, and antiparasitic therapy are administered. HIV/AIDS and tuberculosis (TB) are two common chronic infectious diseases that are treated with injectable medications. Injectable medications like streptomycin, isoniazid, and rifampin are routinely used with oral antibiotics in tuberculosis treatment to effectively target TB germs and prevent medicine resistance. Similarly, injectable antiretrovirals can be used to delay the progression of the HIV/AIDS disease and limit viral replication in treatment regimens. Rising Demand for Biosimilars and Generic Medicine Pharmaceutical industries can expand their product portfolios in the injectable drug delivery industry by utilizing biosimilars and generic pharmaceuticals, which are in high demand. As the need for accessible and reasonably priced therapies grows, businesses can create and produce a broad range of injectable biosimilars and generic medications for many therapeutic areas, such as diabetes, infectious diseases, autoimmune diseases, and cancer. Generic injectables and biosimilars are more accessible to patients, healthcare providers, and healthcare systems due to their lower cost and lower price compared to name-brand pharmaceuticals. A safe, efficient, and convenient delivery method for patients receiving long-term or chronic therapy, injectable drug delivery systems are essential for the administration of biosimilars and generic medications. Challenges: The market for injectable medication delivery technologies is facing significant challenges due to this demand for alternative drug administration routes.The injectable medication administration method delivers quick systemic levels of absorption because it provides a broad surface area for absorption. On the other hand, using injectables might result in discomfort, anxiety, needle phobia, infections, and injuries from sticking oneself. The injectables market is somewhat restricted by all of these issues. The oral route is the most popular method of medication delivery since it is simple to use, practical, affordable, safe, and acceptable among other factors. Due to the large surface area of the pulmonary endothelium, inhalation allows for quick absorption; low systemic absorption lungs might be the target of bronchodilators and inhaled steroids. Since medications are administered topically and are non-invasive, simple, and highly complied with by patients, topical drug delivery is thought to be preferable to injections.Injectable Drug Delivery Market Segment Analysis
By Type, segmented into Formulation and Devices. Within the Formulation category, conventional drug delivery methods such as Suspensions, Solutions, Lyophilized Formulations, and Emulsions remain prevalent. Solutions are particularly dominant due to their widespread use in treatments requiring precise dosing and rapid absorption. However, Lyophilized Formulations are gaining traction for their stability and extended shelf life, especially in the treatment of rare and chronic diseases. Novel Drug Delivery methods, including Long-Acting Injection Formulations, Microparticles, and Colloidal Dispersions, are increasingly popular, particularly in specialized therapeutic areas where sustained drug release is beneficial. Prefilled syringes remain the leading segment in the Devices category of the injectable drug delivery market. Their popularity is mostly attributable to their practicality, simplicity of use, and capacity to lower dosage errors, which make them a top option in both home and clinical contexts. Prefilled syringes are especially popular for vaccinations, biologics, and emergency medications because they provide accurate doses and lower the chance of contamination. Prefilled syringes continue to hold the largest market share despite the rapid growth of wearable and auto-injectors due to the increased focus on patient-centric care and chronic disease management. These injectables are reliable, have a wide range of applications, and are affordable.Injectable Drug Delivery Market Regional Analysis
The Injectable Drug Delivery Market has seen significant growth globally, driven by the increasing prevalence of chronic diseases, advancements in biologics, and patient preference for self-administration options. In 2023, North America held the largest market share, driven by the high adoption of advanced drug delivery systems, the presence of key players, and favorable reimbursement policies. Europe followed closely, with strong demand in countries like Germany, the UK, and France due to robust healthcare infrastructure and a growing elderly population. The Asia-Pacific region is expected to witness the fastest growth, with increasing healthcare investments, rising awareness, and an expanding patient pool in countries like China and India. The objective of the report is to present a comprehensive assessment of the market and contains thoughtful insights, facts, historical data, industry-validated market data and projections with a suitable set of assumptions and methodology. The report also helps in understanding Global Injectable Drug Delivery Market dynamics, structure by identifying and analyzing the market segments and project the global market size. Further, the report also focuses on the competitive analysis of key players by product, price, financial position, product portfolio, growth strategies, and regional presence. The report also provides PEST analysis, PORTER’s analysis, SWOT analysis to address the question of shareholders to prioritizing the efforts and investment in the near future to the emerging segment in Global Injectable Drug Delivery Market.Injectable Drug Delivery Industry Ecosystem
Injectable Drug delivery Market Scope : Inquire before buying
Global Injectable Drug delivery Market Report Coverage Details Base Year: 2023 Forecast Period: 2024-2030 Historical Data: 2018 to 2023 Market Size in 2023: USD 772.99 Billion Forecast Period 2024 to 2030 CAGR: 11.3% Market Size in 2030: USD 1631.3 Billion Segments Covered: by Type Formulation Conventional Drug Delivery Suspensions Solutions Lyophilized Formulations Emulsions Novel Drug Delivery Long Acting Injection Formulation Microparticles Colloidal Dispersions Others Devices Self-Injection Devices Needle-Free Injectors (NFI) Wearable Injectors Pen Injectors Auto-Injectors Others Conventional Injection Devices Prefilled Syringes Fillable Syringes Others by Applications Autoimmune Diseases Oncology Disorders Hormonal Disorders Orphan Diseases Others by End user Home Care Hospital Ambulatory Care Physician Offices or Clinics Others Injectable Drug delivery Market, by Region
Asia Pacific (China, South Korea, Japan, India, Australia, Indonesia, Malaysia, Vietnam, Taiwan, Bangladesh, Pakistan and Rest of APAC) Europe (UK, France, Germany, Italy, Spain, Sweden, Austria and Rest of Europe) North America (United States, Canada and Mexico) Middle East and Africa (South Africa, GCC, Egypt, Nigeria and Rest of ME&A) South America (Brazil, Argentina Rest of South America)Key Players :
1. Baxter International, Inc., 2. Becton Dickinson and Company, 3. Gerresheimer AG, 4. Pfizer, Inc., 5. Schott AG, 6. Alkermes Plc., 7. Eli Lilly and Company, 8. Sandoz, 9. Terumo Corporation, 10. Teva Pharmaceuticals Industries Ltd. 11. Ypsomed, 12. Bespak 13. Unilife Corporation 14. Vetter Pharma-Fertigung GmbH & Co. KG 15. BD 16. SHL Medical AG 17. West Pharmaceutical Services, Inc. 18. Insulate Corporation 19. Elcam Medical 20. B. Braun Melsungen 21. Mylan N.V. 22. Diabnext 23. Biocon 24. Antares Pharma 25. AbbVie Inc. 26. Diabnext 27. SiO2 Medical ProductsFrequently Asked Questions:
1. Which region has the largest Global Injectable Drug Delivery Market share? Ans: The North America region held the highest share in 2023. 2. What is the growth rate of the Global Injectable Drug Delivery Market? Ans: The Global Market is expected to grow at a CAGR of 11.3% from 2024 to 2030. 3. What is the scope of the Global Injectable Drug Delivery market report? Ans: The Global Injectable Drug Delivery Market report helps with the PESTEL, PORTER, Recommendations for Investors & Leaders, and market estimation of the forecast period. 4. Who are the key players in the Global Injectable Drug delivery market? Ans: The major key players in the Global Market are – Baxter International, Inc., Becton, Dickinson and Company (BD), Gerresheimer AG, Pfizer, Inc., Schott AG, Alkermes Plc., and Eli Lilly and Company. 5. What is the study period of this market? Ans: The Global Injectable Drug Delivery Market is studied from 2023 to 2030.
1. Injectable Drug Delivery Market Introduction 1.1. Study Assumption and Market Definition 1.2. Scope of the Study 1.3. Executive Summary 2. Global Injectable Drug Delivery Market: Competitive Landscape 2.1. MMR Competition Matrix 2.2. Competitive Landscape 2.3. Market share analysis of major players 2.4. Products specific analysis 2.5. Key Players Benchmarking 2.5.1. Company Name 2.5.2. Company Location 2.5.3. Product Segment 2.5.4. End-user Segment 2.5.5. Revenue (2023) 2.5.6. Growth Rate (Y-O-Y in %) 2.5.7. Key Development 2.5.8. Market Share 2.6. Industry Ecosystem Analysis 2.7. Market Structure 2.7.1. Market Leaders 2.7.2. Market Followers 2.7.3. Emerging Players 2.8. Consolidation of the Market 2.8.1. Strategic Initiatives and Developments 2.8.2. Mergers and Acquisitions 2.8.3. Collaborations and Partnerships 2.8.4. Product Launches and Innovations 3. Injectable Drug Delivery Market: Dynamics 3.1. Injectable Drug Delivery Market Trends 3.2. Injectable Drug Delivery Market Dynamics 3.2.1. Drivers 3.2.2. Restraints 3.2.3. Opportunities 3.2.4. Challenges 3.3. PORTER’s Five Forces Analysis 3.3.1. Threat of New Entrants 3.3.2. Threat of Substitutes 3.3.3. Bargaining Power of Suppliers 3.3.4. Bargaining Power of Buyers 3.3.5. Intensity of Competitive Rivalry 3.4. PESTLE Analysis 3.5. Supply Chain Analysis 3.5.1. Prominent Companies 3.5.2. Small and Medium-Sized Companies 3.5.3. End Users 3.6. Value Chain Analysis 3.6.1. Research & Development 3.6.2. Procurement & Product Development 3.6.3. Marketing, Sales & Distribution, And Post-Sales Services 3.7. Technological Analysis 3.7.1. Key Technologies 3.7.2. Complimentary Technologies 3.7.3. Adjacent Technologies 3.7.4. Technology Roadmap 3.8. Tariff and Regulatory Landscape 3.8.1. Regulatory Bodies, Government Agencies, and Other Organizations 3.9. Patent Analysis 3.9.1. List of Major Patents On Injectable Drug Delivery (2018 – 2024) 3.9.2. Number of Patents Granted for Injectable Drug Delivery (2018-2023) 3.9.3. Regional Analysis of Patents Granted for Injectable Drug Delivery 3.10. Trends/Disruptions Impacting Customers' Businesses 3.11. Pricing Analysis 3.11.1. Average Selling Price Trend by Region 3.12. Key Stakeholders And Buying Criteria 4. Injectable Drug Delivery Market: Global Market Size and Forecast by Segmentation (by Value in USD Mn & Volume in Units) (2023-2030) 4.1. Injectable Drug Delivery Market Size and Forecast, by Type (2023-2030) 4.1.1. Formulation 4.1.1.1. Conventional Drug Delivery 4.1.1.1.1. Suspensions 4.1.1.1.2. Solutions 4.1.1.1.3. Lyophilized Formulations 4.1.1.1.4. Emulsions 4.1.1.2. Novel Drug Delivery 4.1.1.2.1. Long-Acting Injection Formulation 4.1.1.2.2. Microparticles 4.1.1.2.3. Colloidal Dispersions 4.1.1.3. Others 4.1.2. Devices 4.1.2.1. Self-Injection Devices 4.1.2.1.1. Needle-Free Injectors (NFI) 4.1.2.1.2. Wearable Injectors 4.1.2.1.3. Pen Injectors 4.1.2.1.4. Auto-Injectors 4.1.2.1.5. Others 4.1.2.2. Conventional Injection Devices 4.1.2.2.1. Prefilled Syringes 4.1.2.2.2. Fillable Syringes 4.1.2.2.3. Others 4.2. Injectable Drug Delivery Market Size and Forecast, by Applications (2023-2030) 4.2.1. Autoimmune Diseases 4.2.2. Oncology Disorders 4.2.3. Hormonal Disorders 4.2.4. Orphan Diseases 4.2.5. Others 4.3. Injectable Drug Delivery Market Size and Forecast, by End User (2023-2030) 4.3.1. Home Care 4.3.2. Hospital 4.3.3. Ambulatory Care 4.3.4. Physician Offices or Clinics 4.3.5. Others 4.4. Injectable Drug Delivery Market Size and Forecast, by Region (2023-2030) 4.4.1. North America 4.4.2. Europe 4.4.3. Asia Pacific 4.4.4. Middle East and Africa 4.4.5. South America 5. North America Injectable Drug Delivery Market Size and Forecast by Segmentation (by Value in USD Mn & Volume in Units) (2023-2030) 5.1. North America Injectable Drug Delivery Market Size and Forecast, by Type (2023-2030) 5.1.1. Formulation 5.1.1.1. Conventional Drug Delivery 5.1.1.1.1. Suspensions 5.1.1.1.2. Solutions 5.1.1.1.3. Lyophilized Formulations 5.1.1.1.4. Emulsions 5.1.1.2. Novel Drug Delivery 5.1.1.2.1. Long-Acting Injection Formulation 5.1.1.2.2. Microparticles 5.1.1.2.3. Colloidal Dispersions 5.1.1.3. Others 5.1.2. Devices 5.1.2.1. Self-Injection Devices 5.1.2.1.1. Needle-Free Injectors (NFI) 5.1.2.1.2. Wearable Injectors 5.1.2.1.3. Pen Injectors 5.1.2.1.4. Auto-Injectors 5.1.2.1.5. Others 5.1.2.2. Conventional Injection Devices 5.1.2.2.1. Prefilled Syringes 5.1.2.2.2. Fillable Syringes 5.1.2.2.3. Others 5.2. North America Injectable Drug Delivery Market Size and Forecast, by Applications (2023-2030) 5.2.1. Autoimmune Diseases 5.2.2. Oncology Disorders 5.2.3. Hormonal Disorders 5.2.4. Orphan Diseases 5.2.5. Others 5.3. North America Injectable Drug Delivery Market Size and Forecast, by End User (2023-2030) 5.3.1. Home Care 5.3.2. Hospital 5.3.3. Ambulatory Care 5.3.4. Physician Offices or Clinics 5.3.5. Others 5.4. North America Injectable Drug Delivery Market Size and Forecast, by Country (2023-2030) 5.4.1. United States 5.4.1.1. United States Injectable Drug Delivery Market Size and Forecast, by Type (2023-2030) 5.4.1.1.1. Formulation 5.4.1.1.1.1. Conventional Drug Delivery 5.4.1.1.1.1.1. Suspensions 5.4.1.1.1.1.2. Solutions 5.4.1.1.1.1.3. Lyophilized Formulations 5.4.1.1.1.1.4. Emulsions 5.4.1.1.1.2. Novel Drug Delivery 5.4.1.1.1.2.1. Long-Acting Injection Formulation 5.4.1.1.1.2.2. Microparticles 5.4.1.1.1.2.3. Colloidal Dispersions 5.4.1.1.1.3. Other 5.4.1.1.2. Devices 5.4.1.1.2.1. Self-Injection Devices 5.4.1.1.2.1.1. Needle-Free Injectors (NFI) 5.4.1.1.2.1.2. Wearable Injectors 5.4.1.1.2.1.3. Pen Injectors 5.4.1.1.2.1.4. Auto-Injectors 5.4.1.1.2.1.5. Others 5.4.1.1.2.2. Conventional Injection Devices 5.4.1.1.2.2.1. Prefilled Syringes 5.4.1.1.2.2.2. Fillable Syringes 5.4.1.1.2.2.3. Others 5.4.1.2. United States Injectable Drug Delivery Market Size and Forecast, by Applications (2023-2030) 5.4.1.2.1. Autoimmune Diseases 5.4.1.2.2. Oncology Disorders 5.4.1.2.3. Hormonal Disorders 5.4.1.2.4. Orphan Diseases 5.4.1.2.5. Others 5.4.1.3. United States Injectable Drug Delivery Market Size and Forecast, by End User (2023-2030) 5.4.1.3.1. Home Care 5.4.1.3.2. Hospital 5.4.1.3.3. Ambulatory Care 5.4.1.3.4. Physician Offices or Clinics 5.4.1.3.5. Others 5.4.2. Canada 5.4.2.1. Canada Injectable Drug Delivery Market Size and Forecast, by Type (2023-2030) 5.4.2.1.1. Formulation 5.4.2.1.1.1. Conventional Drug Delivery 5.4.2.1.1.1.1. Suspensions 5.4.2.1.1.1.2. Solutions 5.4.2.1.1.1.3. Lyophilized Formulations 5.4.2.1.1.1.4. Emulsions 5.4.2.1.1.2. Novel Drug Delivery 5.4.2.1.1.2.1. Long-Acting Injection Formulation 5.4.2.1.1.2.2. Microparticles 5.4.2.1.1.2.3. Colloidal Dispersions 5.4.2.1.1.3. Other 5.4.2.1.2. Devices 5.4.2.1.2.1. Self-Injection Devices 5.4.2.1.2.1.1. Needle-Free Injectors (NFI) 5.4.2.1.2.1.2. Wearable Injectors 5.4.2.1.2.1.3. Pen Injectors 5.4.2.1.2.1.4. Auto-Injectors 5.4.2.1.2.1.5. Others 5.4.2.1.2.2. Conventional Injection Devices 5.4.2.1.2.2.1. Prefilled Syringes 5.4.2.1.2.2.2. Fillable Syringes 5.4.2.1.2.2.3. Others 5.4.2.2. Canada Injectable Drug Delivery Market Size and Forecast, by Applications (2023-2030) 5.4.2.2.1. Autoimmune Diseases 5.4.2.2.2. Oncology Disorders 5.4.2.2.3. Hormonal Disorders 5.4.2.2.4. Orphan Diseases 5.4.2.2.5. Others 5.4.2.3. Canada Injectable Drug Delivery Market Size and Forecast, by End User (2023-2030) 5.4.2.3.1. Home Care 5.4.2.3.2. Hospital 5.4.2.3.3. Ambulatory Care 5.4.2.3.4. Physician Offices or Clinics 5.4.2.3.5. Others 5.4.3. Mexico 5.4.3.1. Mexico Injectable Drug Delivery Market Size and Forecast, by Type (2023-2030) 5.4.3.1.1. Formulation 5.4.3.1.1.1. Conventional Drug Delivery 5.4.3.1.1.1.1. Suspensions 5.4.3.1.1.1.2. Solutions 5.4.3.1.1.1.3. Lyophilized Formulations 5.4.3.1.1.1.4. Emulsions 5.4.3.1.1.2. Novel Drug Delivery 5.4.3.1.1.2.1. Long-Acting Injection Formulation 5.4.3.1.1.2.2. Microparticles 5.4.3.1.1.2.3. Colloidal Dispersions 5.4.3.1.1.3. Other 5.4.3.1.2. Devices 5.4.3.1.2.1. Self-Injection Devices 5.4.3.1.2.1.1. Needle-Free Injectors (NFI) 5.4.3.1.2.1.2. Wearable Injectors 5.4.3.1.2.1.3. Pen Injectors 5.4.3.1.2.1.4. Auto-Injectors 5.4.3.1.2.1.5. Others 5.4.3.1.2.2. Conventional Injection Devices 5.4.3.1.2.2.1. Prefilled Syringes 5.4.3.1.2.2.2. Fillable Syringes 5.4.3.1.2.2.3. Others 5.4.3.2. Mexico Injectable Drug Delivery Market Size and Forecast, by Applications (2023-2030) 5.4.3.2.1. Autoimmune Diseases 5.4.3.2.2. Oncology Disorders 5.4.3.2.3. Hormonal Disorders 5.4.3.2.4. Orphan Diseases 5.4.3.2.5. Others 5.4.3.3. Mexico Injectable Drug Delivery Market Size and Forecast, by End User (2023-2030) 5.4.3.3.1. Home Care 5.4.3.3.2. Hospital 5.4.3.3.3. Ambulatory Care 5.4.3.3.4. Physician Offices or Clinics 5.4.3.3.5. Others 6. Europe Injectable Drug Delivery Market Size and Forecast by Segmentation (by Value in USD Mn & Volume in Units) (2023-2030) 6.1. Europe Injectable Drug Delivery Market Size and Forecast, by Type (2023-2030) 6.2. Europe Injectable Drug Delivery Market Size and Forecast, by Applications (2023-2030) 6.3. Europe Injectable Drug Delivery Market Size and Forecast, by End User (2023-2030) 6.4. Europe Injectable Drug Delivery Market Size and Forecast, by Country (2023-2030) 6.4.1. United Kingdom 6.4.1.1. United Kingdom Injectable Drug Delivery Market Size and Forecast, by Type (2023-2030) 6.4.1.2. United Kingdom Injectable Drug Delivery Market Size and Forecast, by Applications (2023-2030) 6.4.1.3. United Kingdom Injectable Drug Delivery Market Size and Forecast, by End User (2023-2030) 6.4.2. France 6.4.2.1. France Injectable Drug Delivery Market Size and Forecast, by Type (2023-2030) 6.4.2.2. France Injectable Drug Delivery Market Size and Forecast, by Applications (2023-2030) 6.4.2.3. France Injectable Drug Delivery Market Size and Forecast, by End User (2023-2030) 6.4.3. Germany 6.4.3.1. Germany Injectable Drug Delivery Market Size and Forecast, by Type (2023-2030) 6.4.3.2. Germany Injectable Drug Delivery Market Size and Forecast, by Applications (2023-2030) 6.4.3.3. Germany Injectable Drug Delivery Market Size and Forecast, by End User (2023-2030) 6.4.4. Italy 6.4.4.1. Italy Injectable Drug Delivery Market Size and Forecast, by Type (2023-2030) 6.4.4.2. Italy Injectable Drug Delivery Market Size and Forecast, by Applications (2023-2030) 6.4.4.3. Italy Injectable Drug Delivery Market Size and Forecast, by End User (2023-2030) 6.4.5. Spain 6.4.5.1. Spain Injectable Drug Delivery Market Size and Forecast, by Type (2023-2030) 6.4.5.2. Spain Injectable Drug Delivery Market Size and Forecast, by Applications (2023-2030) 6.4.5.3. Spain Injectable Drug Delivery Market Size and Forecast, by End User (2023-2030) 6.4.6. Sweden 6.4.6.1. Sweden Injectable Drug Delivery Market Size and Forecast, by Type (2023-2030) 6.4.6.2. Sweden Injectable Drug Delivery Market Size and Forecast, by Applications (2023-2030) 6.4.6.3. Sweden Injectable Drug Delivery Market Size and Forecast, by End User (2023-2030) 6.4.7. Russia 6.4.7.1. Russia Injectable Drug Delivery Market Size and Forecast, by Type (2023-2030) 6.4.7.2. Russia Injectable Drug Delivery Market Size and Forecast, by Applications (2023-2030) 6.4.7.3. Russia Injectable Drug Delivery Market Size and Forecast, by End User (2023-2030) 6.4.8. Rest of Europe 6.4.8.1. Rest of Europe Injectable Drug Delivery Market Size and Forecast, by Type (2023-2030) 6.4.8.2. Rest of Europe Injectable Drug Delivery Market Size and Forecast, by Applications (2023-2030) 6.4.8.3. Rest of Europe Injectable Drug Delivery Market Size and Forecast, by End User (2023-2030) 7. Asia Pacific Injectable Drug Delivery Market Size and Forecast by Segmentation (by Value in USD Mn & Volume in Units) (2023-2030) 7.1. Asia Pacific Injectable Drug Delivery Market Size and Forecast, by Type (2023-2030) 7.2. Asia Pacific Injectable Drug Delivery Market Size and Forecast, by Applications (2023-2030) 7.3. Asia Pacific Injectable Drug Delivery Market Size and Forecast, by End User (2023-2030) 7.4. Asia Pacific Injectable Drug Delivery Market Size and Forecast, by Industry (2023-2030) 7.5. Asia Pacific Injectable Drug Delivery Market Size and Forecast, by Country (2023-2030) 7.5.1. China 7.5.1.1. China Injectable Drug Delivery Market Size and Forecast, by Type (2023-2030) 7.5.1.2. China Injectable Drug Delivery Market Size and Forecast, by Applications (2023-2030) 7.5.1.3. China Injectable Drug Delivery Market Size and Forecast, by End User (2023-2030) 7.5.2. S Korea 7.5.2.1. S Korea Injectable Drug Delivery Market Size and Forecast, by Type (2023-2030) 7.5.2.2. S Korea Injectable Drug Delivery Market Size and Forecast, by Applications (2023-2030) 7.5.2.3. S Korea Injectable Drug Delivery Market Size and Forecast, by End User (2023-2030) 7.5.3. Japan 7.5.3.1. Japan Injectable Drug Delivery Market Size and Forecast, by Type (2023-2030) 7.5.3.2. Japan Injectable Drug Delivery Market Size and Forecast, by Applications (2023-2030) 7.5.3.3. Japan Injectable Drug Delivery Market Size and Forecast, by End User (2023-2030) 7.5.4. India 7.5.4.1. India Injectable Drug Delivery Market Size and Forecast, by Type (2023-2030) 7.5.4.2. India Injectable Drug Delivery Market Size and Forecast, by Applications (2023-2030) 7.5.4.3. India Injectable Drug Delivery Market Size and Forecast, by End User (2023-2030) 7.5.5. Australia 7.5.5.1. Australia Injectable Drug Delivery Market Size and Forecast, by Type (2023-2030) 7.5.5.2. Australia Injectable Drug Delivery Market Size and Forecast, by Applications (2023-2030) 7.5.5.3. Australia Injectable Drug Delivery Market Size and Forecast, by End User (2023-2030) 7.5.6. ASEAN 7.5.6.1. ASEAN Injectable Drug Delivery Market Size and Forecast, by Type (2023-2030) 7.5.6.2. ASEAN Injectable Drug Delivery Market Size and Forecast, by Applications (2023-2030) 7.5.6.3. ASEAN Injectable Drug Delivery Market Size and Forecast, by End User (2023-2030) 7.5.7. Rest of Asia Pacific 7.5.7.1. Rest of Asia Pacific Injectable Drug Delivery Market Size and Forecast, by Type (2023-2030) 7.5.7.2. Rest of Asia Pacific Injectable Drug Delivery Market Size and Forecast, by Applications (2023-2030) 7.5.7.3. Rest of Asia Pacific Injectable Drug Delivery Market Size and Forecast, by End User (2023-2030) 8. Middle East and Africa Injectable Drug Delivery Market Size and Forecast by Segmentation (by Value in USD Mn & Volume in Units) (2023-2030) 8.1. Middle East and Africa Injectable Drug Delivery Market Size and Forecast, by Type (2023-2030) 8.2. Middle East and Africa Injectable Drug Delivery Market Size and Forecast, by Applications (2023-2030) 8.3. Middle East and Africa Injectable Drug Delivery Market Size and Forecast, by End User (2023-2030) 8.4. Middle East and Africa Injectable Drug Delivery Market Size and Forecast, by Country (2023-2030) 8.4.1. South Africa 8.4.1.1. South Africa Injectable Drug Delivery Market Size and Forecast, by Type (2023-2030) 8.4.1.2. South Africa Injectable Drug Delivery Market Size and Forecast, by Applications (2023-2030) 8.4.1.3. South Africa Injectable Drug Delivery Market Size and Forecast, by End User (2023-2030) 8.4.2. GCC 8.4.2.1. GCC Injectable Drug Delivery Market Size and Forecast, by Type (2023-2030) 8.4.2.2. GCC Injectable Drug Delivery Market Size and Forecast, by Applications (2023-2030) 8.4.2.3. GCC Injectable Drug Delivery Market Size and Forecast, by End User (2023-2030) 8.4.3. Rest of ME&A 8.4.3.1. Rest of ME&A Injectable Drug Delivery Market Size and Forecast, by Type (2023-2030) 8.4.3.2. Rest of ME&A Injectable Drug Delivery Market Size and Forecast, by Applications (2023-2030) 8.4.3.3. Rest of ME&A Injectable Drug Delivery Market Size and Forecast, by End User (2023-2030) 9. South America Injectable Drug Delivery Market Size and Forecast by Segmentation (by Value in USD Mn & Volume in Units) (2023-2030 9.1. South America Injectable Drug Delivery Market Size and Forecast, by Type (2023-2030) 9.2. South America Injectable Drug Delivery Market Size and Forecast, by Applications (2023-2030) 9.3. South America Injectable Drug Delivery Market Size and Forecast, by End User (2023-2030) 9.4. South America Injectable Drug Delivery Market Size and Forecast, by Country (2023-2030) 9.4.1. Brazil 9.4.1.1. Brazil Injectable Drug Delivery Market Size and Forecast, by Type (2023-2030) 9.4.1.2. Brazil Injectable Drug Delivery Market Size and Forecast, by Applications (2023-2030) 9.4.1.3. Brazil Injectable Drug Delivery Market Size and Forecast, by End User (2023-2030) 9.4.2. Argentina 9.4.2.1. Argentina Injectable Drug Delivery Market Size and Forecast, by Type (2023-2030) 9.4.2.2. Argentina Injectable Drug Delivery Market Size and Forecast, by Applications (2023-2030) 9.4.2.3. Argentina Injectable Drug Delivery Market Size and Forecast, by End User (2023-2030) 9.4.3. Rest Of South America 9.4.3.1. Rest Of South America Injectable Drug Delivery Market Size and Forecast, by Type (2023-2030) 9.4.3.2. Rest Of South America Injectable Drug Delivery Market Size and Forecast, by Applications (2023-2030) 9.4.3.3. Rest Of South America Injectable Drug Delivery Market Size and Forecast, by End User (2023-2030) 10. Company Profile: Key Players 10.1. Baxter International, Inc. 10.1.1. Company Overview 10.1.2. Business Portfolio 10.1.3. Financial Overview 10.1.4. SWOT Analysis 10.1.5. Strategic Analysis 10.1.6. Scale of Operation (small, medium, and large) 10.1.7. Details on Partnership 10.1.8. Regulatory Accreditations and Certifications Received by Them 10.1.9. Awards Received by the Firm 10.1.10. Recent Developments 10.2. Becton, Dickinson and Company (BD) 10.3. Gerresheimer AG 10.4. Pfizer, Inc. 10.5. Schott AG 10.6. Alkermes Plc. 10.7. Eli Lilly and Company 10.8. Sandoz 10.9. Terumo Corporation 10.10. Teva Pharmaceuticals Industries Ltd. 10.11. Ypsomed 10.12. Bespak 10.13. Unilife Corporation 10.14. Vetter Pharma-Fertigung GmbH & Co. KG 10.15. SHL Medical AG 10.16. West Pharmaceutical Services, Inc. 10.17. Elcam Medical 10.18. B. Braun Melsungen 10.19. Mylan N.V. 10.20. Biocon 10.21. Antares Pharma 10.22. AbbVie Inc. 10.23. SiO2 Medical Products 11. Key Findings & Analyst Recommendations 12. Injectable Drug Delivery Market: Research Methodology 12.1.1. Top-Down Approach 12.1.2. Bottom-up Approach
